StockData
Monopar Therapeutics logo

Monopar Therapeutics (MNPR) KPIs and segments

MNPRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$71.06−0.91 (-1.26%)

Close on Nov 17, 2026Market cap $476.97MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Monopar Therapeutics's business

Coming soon

This tab will track the numbers specific to Monopar Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?